Lead
Measles cases surged after 2025 and the virus continues to spread into 2026, with 733 cases reported nationwide so far and a large outbreak in South Carolina that has sickened more than 900 people since last fall. Most recent infections have been among unvaccinated individuals, prompting renewed public-health appeals and targeted responses in affected states. Health officials emphasize how easily measles travels through respiratory droplets and the importance of vaccination to blunt transmission. This guide summarizes symptoms, transmission, prevention, treatment and what to watch next.
Key Takeaways
- There were more measles cases in the United States in 2025 than in recent years; 733 cases have been recorded nationwide so far in 2026.
- South Carolina is facing a major outbreak that has sickened more than 900 people—mostly children—since it began last fall.
- Vaccination coverage has dropped below the herd-immunity threshold: 92.5% of U.S. kindergartners received MMR in 2024–25, under the roughly 95% level experts recommend.
- Measles spreads through respiratory droplets and airborne particles that can linger for hours; infected people can be contagious days before symptoms appear.
- Public-health leaders, including the head of the Centers for Medicare and Medicaid Services, have urged eligible people to get MMR vaccinations to curb further spread.
- Complications from measles—such as pneumonia and encephalitis—remain uncommon but can be severe, especially in young children and immunocompromised people.
Background
Measles is one of the most infectious viral diseases known; historically it caused widespread illness before vaccines were widely available. Routine two-dose MMR (measles-mumps-rubella) vaccination introduced in the late 20th century drove case counts down dramatically in the United States. In recent years, however, pockets of undervaccinated populations and rising vaccine hesitancy have created conditions favorable to outbreaks.
Public-health experts say population-level protection typically requires around 95% coverage with two MMR doses to prevent sustained transmission. The Centers for Disease Control and Prevention reported a 92.5% MMR uptake among kindergartners in the 2024–25 school year, leaving gaps in immunity where the virus can take hold. International importation also plays a role: measles remains common in some other countries, and travelers can reintroduce the virus to susceptible U.S. communities.
Main Event
The current wave began in late 2025 and intensified in early 2026. South Carolina’s outbreak, first identified last fall, has grown rapidly and primarily affected children in communities with low vaccination rates. State health departments and federal partners have deployed testing, contact tracing and targeted vaccination clinics to slow transmission.
Outbreaks have been reported in multiple states including Utah and Arizona, with cases concentrated in underimmunized groups. Clinicians report typical presentations starting with high fever, cough, runny nose and red eyes, followed by the characteristic rash that spreads from the face downward. Because infected people can transmit the virus before the rash appears, containment is more difficult than for many other childhood illnesses.
Hospitals and pediatric practices in affected areas have expanded screening and isolation protocols to reduce nosocomial spread. Public-health messaging has focused on verifying vaccination records, offering catch-up MMR doses, and advising anyone exposed or symptomatic to contact health services promptly. Federal officials have issued reminders that MMR remains the primary preventive measure.
Analysis & Implications
At a population level, measles outbreaks reveal both coverage gaps and vulnerabilities in public-health infrastructure. When coverage slips below the roughly 95% level needed for herd immunity, localized outbreaks can grow quickly; the 92.5% kindergarten MMR rate from 2024–25 illustrates how modest declines in uptake increase outbreak risk. The result is not only higher case counts, but also greater strain on local health systems and schools that must respond to exposures and quarantine orders.
The economic and social costs extend beyond direct health care: outbreak responses require staff time for contact tracing, costs for vaccination clinics, and disruptions when schools or childcare centers limit attendance. Children who miss routine immunizations for any reason—access, hesitancy or misinformation—are at higher risk, and disparities in access can concentrate illness in already vulnerable communities. International travel and uneven global control of measles mean importations will continue to seed outbreaks unless domestic immunity remains high.
In the short term, increasing access to MMR through clinics, school-based programs and community outreach is the most effective intervention. In the medium term, rebuilding public confidence in vaccines will matter: clear, consistent messaging from trusted local clinicians and community leaders tends to be more persuasive than distant warnings. Policy levers—school-entry requirements and catch-up campaign funding—can raise coverage quickly, but they require political will and operational support.
Comparison & Data
| Metric | Value | Period / Source |
|---|---|---|
| U.S. cases recorded in 2026 (so far) | 733 | 2026, national case counts |
| South Carolina outbreak cases | >900 (since last fall) | Outbreak timeline: fall 2025–2026 |
| Kindergarten MMR coverage (U.S.) | 92.5% | 2024–25 school year, CDC |
| Estimated herd-immunity threshold | ~95% | Public-health guidance |
The table highlights how current vaccination coverage compares with the level typically recommended to prevent sustained measles transmission. Even a few percentage points below the threshold can leave thousands of children susceptible in aggregate, and localized clustering of unvaccinated individuals amplifies risk.
Reactions & Quotes
Public-health leaders and clinicians have responded with urgent appeals for vaccination and for communities to verify records.
“Take the vaccine, please,”
Dr. Mehmet Oz, Centers for Medicare and Medicaid Services
This direct plea from the CMS leader aimed to underscore the immediate preventive action available to most people: MMR vaccination.
“Measles is so contagious that if one person has it, up to 90% of the people close to that person who are not immune will also become infected,”
Centers for Disease Control and Prevention (CDC)
The CDC language is often used to explain why measles requires very high vaccination coverage to prevent outbreaks and why exposures can produce rapid chains of transmission.
Unconfirmed
- Whether a single specific event or location seeded the multi-state spread remains under investigation; sequencing and contact-tracing are ongoing.
- The relative contribution of waning immunity versus primary nonvaccination to current cases is not yet fully quantified.
Bottom Line
Measles is circulating more widely than it has in recent years because of gaps in vaccination coverage and the disease’s high transmissibility. The most reliable way to prevent infection for individuals and communities is timely MMR vaccination—two doses for children and catch-up doses for those without documentation of immunity.
Local and federal health authorities are responding with testing, vaccination clinics and public information campaigns; the coming weeks will show how effectively those measures contain transmission. Readers should check vaccination records, seek MMR vaccination if not up to date, and consult local health departments for guidance after any known exposure.
Sources
- The New York Times — News report summarizing outbreak and public-health responses (media).
- Centers for Disease Control and Prevention (CDC) — Vaccination coverage and measles transmission guidance (official public-health data).
- South Carolina Department of Health and Environmental Control (SCDHEC) — State health department outbreak information (official state agency).